Johnson & Johnson : advances leadership in oncology innovation with more than 75 clinical study and real-world presentations at ASCO and EHA
Media contacts: Investor contact: ...
Source: marketscreener.com
📰 Solid Tumor News
Solid Tumor News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Solid Tumor. Real-time updates on events, politics, business and more.
Fighting Cancer: A Basic Guide To Checkpoint Inhibitors
People with cancer may encounter checkpoint inhibitors as a treatment option but may not know where to start. This article can help you learn more.
Bristol Myers Squibb Chimeric Antigen Receptort Cell Therapy Consider Checkpoint Microsatellite Instability High Bristol Myers Procedure Look
Source: forbes.com
Faculty position, Department of Oncology – Solid Tumor Division job with St. Jude Children's Research Hospital (St. Jude)
Faculty position, Department of Oncology – Solid Tumor Division job in Memphis, Tennessee with St. Jude Children's Research Hospital (St. Jude). Apply Today.
Danny Thomas Sara Federico Fortune Magazine Jude Children Research Hospital Jude Comprehensive Cancer Center Department Of Oncology
Source: nature.com
11 hospitals closing departments or ending services
Here are department closures or services ending, announced, advanced or finalized that Beckers has reported since Jan. 19:
Source: beckershospitalreview.com
Sacituzumab Govitecan Plus Pembrolizumab Proves Active in Advanced Urothelial Carcinoma
Sacituzumab govitecan and pembrolizumab can produce a high response rate in previously treated, advanced urothelial carcinoma, according to researchers. Sacituzumab govitecan and pembrolizumab can produce a high response rate in previously treated, advanced urothelial carcinoma, according to researchers.
Source: renalandurologynews.com
Europe MRD Testing Market Report 2024: Analysis and
Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The
Company Profiles European Union Laboratory Developed Tests Ldts Roche Ltd Criteria For Company Company Overview
Source: globenewswire.com
Europe MRD Testing Market Report 2024: Market to Reach $1.74 Billion by 2033 from $420 Million in 2023, Driven by Advancements and Increased Awareness
/PRNewswire/ -- The "Europe MRD Testing Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.coms offering. The Europe MRD...
Laura Wood E St Office Hours Call Company Profiles Criteria For Company Research Methodology Roche Ltd
Source: prnewswire.com
Sacituzumab Govitecan Plus Pembrolizumab Proves Active in Advanced Urothelial Carcinoma
Sacituzumab govitecan and pembrolizumab can produce a high response rate in previously treated, advanced urothelial carcinoma, according to researchers. Sacituzumab govitecan and pembrolizumab can produce a high response rate in previously treated, advanced urothelial carcinoma, according to researchers.
Source: cancertherapyadvisor.com
Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics
SALT LAKE CITY, Feb. 01, 2024 -- Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced it has completed the acquisition from Intermountain Health of select...
Source: marketscreener.com
Myriad Genetics Completes Acquisition of Precise Tumor,
SALT LAKE CITY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today...
Source: globenewswire.com